Ensured fitness for clinical use and drove global product strategy for an FDA Class III medical device granted Breakthrough Device designation from Performance Qualification, multi-national Pivotal Study execution, and international Regulatory submissions (NCT03728985) and commercial launch. > Responsible for a team of Product Specialists (Product Managers) and Clinical Specialists in the global thoracic aortic business > Influenced within a matrixed organization across regulatory, clinical, health economics, technical, supply chain, sales and marketing in support of clinical study execution and launch readiness > Developed product training plan in partnership with physician key opinion leaders, with delivery to over 200 Vascular Surgeons, Cardiothoracic Surgeons and Interventional Radiologists > Drove multiple Failure Investigations and Adverse Event investigations and risk assessments, with implementation of associated mitigations > Supported global regulatory consultation meetings and submissions (FDA, PMDA, BSI, NMPA, ANVISA) Championed and drove creation of a product development roadmap for a new Vascular business unit (Visceral Aortic), resulting in initiation of two additional NPD projects aligning customer needs with divisional portfolio strategy

> Worked cross functionally with engineering, operations, regulatory compliance, and sales & marketing in support of a global portfolio of vascular grafts, generating >$125M annual revenue and increasing YoY profit.> Developed and implemented global and regional product strategies to defend market leadership position from new market entrants, pricing pressure, and increasing regulatory requirements.> Drove evaluation and alignment of a physician initiated randomized study with respect to broad long-term portfolio strategies related to regional expansion, conversion to the premium product offering, and development of clinic-economic evidence.

Analyze performance data of TVL Accelerator alumni companies and students.Generate reports of TVL reach and impact for outside sponsors.Recruit, mentor, and evaluate companies applying to Venture Labs Investment Competitions.

Three year fellowship supporting graduate research on the development of imaging contrast agents to be used during the diagnosis and treatment of cardiovascular disease. The research incorporated nanoparticle synthesis and combined ultrasound and photoactoustic imaging system design with the end goal of translating improved technologies to diagnose and treat high-risk atherosclerotic plaques into clinical practice.

Research focused on the development of a diagnostic imaging catheter intended to aid in the diagnosis and treatment of cardiovascular disease.

Led cross-functional graduate student teams on consulting projects for four TVL Accelerator companies within the life sciences, IT, and education industries. Projects included market validation, competitive analysis, and development of funding strategies, as well as cooperating with the Central Texas Angel Network to aid in reaching an investment decision for a software company focused on the legal industry.

Synthesized fluorescent ion indicator dyes to facilitate preclinical and drug discovery research.Characterized product purity and verified quality assurance.

Developed simulation of device performance and established benchmarking metrics.Facilitated device prototype and signal processing algorithm development. Conducted prior art literature and patent searches; prepared patent specifications drafts.Led prototype demonstrations to potential investors and customers during due diligence.